← Back to Clinical Trials
Recruiting NCT06664359

Safe Zone in Trigger Point Injection

Trial Parameters

Condition Trigger Point Pain, Myofascial
Sponsor Ankara University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 211
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-10-01
Completion 2024-12-30
Interventions
Ultrasound guided injection with local anaestethicUltrasound guided injection with local anaestethic

Brief Summary

The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question\[s\] it aims to answer \[is/are\]: The mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation

Eligibility Criteria

Inclusion Criteria: * patients diagnosed with Myofascial Pain Syndrome * patients scheduled for trigger point injections due to Myofascial Pain Syndrome. Exclusion Criteria: * under 18 years of age, * additional diseases other than Myofascial Pain Syndrome, * the presence of active infection in the interscapular area where ultrasound imaging and measurements will be performed, * lesions that disrupt skin integrity or affect subcutaneous and muscle structures such as anomalies or masses that could impair imaging quality * individuals with known lung diseases * not consent to participate in the study."

Related Trials